Literature DB >> 3124290

The extrinsic fibrinolytic system in survivors of myocardial infarction.

T K Nilsson1, O Johnson.   

Abstract

The extrinsic fibrinolytic system was assessed among 124 consecutive survivors of acute myocardial infarction below 70 years of age. In samples drawn 3 months after discharge from hospital, the PAI-1 levels were higher and the tPA activities were lower than among elderly healthy controls. In contrast, the AMI survivors had higher tPA antigen levels at rest and after venous occlusion, and higher tPA activities after venous occlusion. Among patients having PAI-1 levels greater than 10 IU/ml, there was a positive correlation between PAI-1 and serum triglycerides, and a negative correlation between PAI-1 and age; this group was also significantly younger than the subgroup having less than or equal to 10 IU/ml of PAI-1. There were thus multiple disturbances of the extrinsic fibrinolytic system among these patients. As cardiovascular risk factors, these disturbances appear to be relatively more important the younger the patients are.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3124290     DOI: 10.1016/0049-3848(87)90428-2

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  10 in total

1.  Effects of doxazosin and atenolol on the fibrinolytic system in patients with hypertension and elevated serum cholesterol.

Authors:  J H Jansson; B Johansson; K Boman; T K Nilsson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Decreased fibrinolytic capacity and increased von Willebrand factor levels as indicators of endothelial cell dysfunction in patients with lupus anticoagulant.

Authors:  T K Nilsson; E Löfvenberg
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

3.  Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic men.

Authors:  A Asplund-Carlson; A Hamsten; B Wiman; L A Carlson
Journal:  Diabetologia       Date:  1993-09       Impact factor: 10.122

4.  Baseline plasma fibrinolysis and its correlation with clinical manifestations in patients with Raynaud's phenomenon.

Authors:  C S Lau; M McLaren; I Mackay; J J Belch
Journal:  Ann Rheum Dis       Date:  1993-06       Impact factor: 19.103

5.  von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10 year follow up of survivors of acute myocardial infarction.

Authors:  J H Jansson; T K Nilsson; O Johnson
Journal:  Heart       Date:  1998-10       Impact factor: 5.994

Review 6.  Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis.

Authors:  I Juhan-Vague; M C Alessi; P Vague
Journal:  Diabetologia       Date:  1991-07       Impact factor: 10.122

7.  Increased tissue-plasminogen activator (t-PA) levels in patients under oral anticoagulant therapy.

Authors:  J Grulich-Henn; K Loechelt; W Speiser; G Müller-Berghaus
Journal:  Blut       Date:  1989-01

8.  Defibrotide versus heparin in the prevention of coronary reocclusion after thrombolysis in acute myocardial infarction.

Authors:  M Tubaro; G Mattioli; F Matta; C Cappello; E Natale; R Ricci; P Gerardi; F Milazzotto
Journal:  Cardiovasc Drugs Ther       Date:  1993-11       Impact factor: 3.727

9.  von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death.

Authors:  J H Jansson; T K Nilsson; O Johnson
Journal:  Br Heart J       Date:  1991-11

10.  Evaluation of prothrombin time and activated partial thromboplastin time in hypertensive patients attending a tertiary hospital in calabar, Nigeria.

Authors:  Nnamani Nnenna Adaeze; Anthony Uchenna Emeribe; Idris Abdullahi Nasiru; Adamu Babayo; Emmanuel K Uko
Journal:  Adv Hematol       Date:  2014-11-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.